Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Foundation of Cardiovascular Research and Education Enschede
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Minimum age of 18 years.
Significant coronary artery disease and lesion(s) eligible for treatment with drug eluting stents according to clinical guidelines and/or the operators' judgement.
Capable of providing informed consent.
Patients with all clinical syndromes will be enrolled without any exclusion based on number, type, location, or length of lesions to be treated.
You may not be if
Known intolerance to components of one of the stents that will be investigated or known intolerance to antithrombotic and/or anticoagulant therapy that prevents adherence to dual antiplatelet therapy.
Planned elective surgical procedure necessitating interruption of dual antiplatelet therapy during the first 6 months after randomization.
Participation in another randomized drug or device trial before reaching primary endpoint.
Adherence to scheduled follow-up is unlikely or life expectancy assumed to be less than 1 year.
Known pregnancy
Clareo Health | Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT)
